NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells show promise against hard-to-treat childhood blood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. Researchers took participants' white blood cells, modified them in a lab to target the CD22 protein on cancer cells, and infused …
Matched conditions: NHL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
New combo tackles tough lymphomas
Disease control CompletedThis study tested a three-drug combination (VIP152, venetoclax, and prednisone) in 8 adults with aggressive non-Hodgkin lymphomas that had not responded to or returned after prior treatment. The main goals were to check safety and find the best dose. Participants took pills at ho…
Matched conditions: NHL
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:47 UTC